NCT05052463

Brief Summary

The type and severity of electrolyte imbalance in patients admitted to the intensive care unit were analyzed.It was evaluated whether these results had an effect on mortality, length of hospital stay, APACHE II scores and ventilator days

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
824

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Dec 2019

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 10, 2019

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 5, 2021

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 15, 2021

Completed
18 days until next milestone

First Submitted

Initial submission to the registry

September 2, 2021

Completed
20 days until next milestone

First Posted

Study publicly available on registry

September 22, 2021

Completed
Last Updated

September 28, 2021

Status Verified

September 1, 2021

Enrollment Period

1.3 years

First QC Date

September 2, 2021

Last Update Submit

September 22, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • The analysis the electrolyte imbalance in ICU and the relationship between the icu prognosis.

    Natremia (Hypo: \<136 mmol/L, Normo: 136-145 mmol/L, Hyper: \>145 mmol/L) Kalemia (Hypo: \<3.5 mmol/L, Normo: 3.5-5.5 mmol/L, Hyper: \>5.5 mmol/L) Calcemia (Hypo: \<8.8 mg/dL, Normo: 8.8-10.6 mg/dL, Hyper: \>10.6 mg/dL) Magnesemia (Hypo: \<1.9 mg/dL, Normo: 1.9-2.5 mg/dL, Hyper: \>2.5 mg/dL) Phosphatemia (Hypo: \<2.5 mg/dL, Normo: 2.5-4.5 mg/dL, Hyper: \>4.5 mg/dL) The number of patients in all types of electrolyte imbalance will be determined. The effect of the type of electrolyte imbalance on mortality, APACHE-II score and length of invasive ventilation and hospital stay will be evaluated.

    2 years

Study Arms (5)

sodium (hypo-hyper-normonatremia)

Other: electrolyte imbalance analysis

potassium (hypo-hyper-normokalemia)

Other: electrolyte imbalance analysis

calcium (hyper-hypo-normocalcemia)

Other: electrolyte imbalance analysis

magnesium (hyper-hypo-normocalcemia)

Other: electrolyte imbalance analysis

phosphor (hypo-hyper-normophosphatemia)

Other: electrolyte imbalance analysis

Interventions

ın this retrospective study we aimed to evaluate the relationship between the ıcu prognosis and the electrolyte imbalance

calcium (hyper-hypo-normocalcemia)magnesium (hyper-hypo-normocalcemia)phosphor (hypo-hyper-normophosphatemia)potassium (hypo-hyper-normokalemia)sodium (hypo-hyper-normonatremia)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

ıcu patients

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ankara Kecioren Training and Research Hospital

Ankara, Çankaya, Turkey (Türkiye)

Location

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Head of Anesthesiology and Reanimation Department

Study Record Dates

First Submitted

September 2, 2021

First Posted

September 22, 2021

Study Start

December 10, 2019

Primary Completion

April 5, 2021

Study Completion

August 15, 2021

Last Updated

September 28, 2021

Record last verified: 2021-09

Data Sharing

IPD Sharing
Will not share

Locations